Net profit of Emcure Pharmaceuticals rose 33.73% to Rs 325.57 crore in the quarter ended September 2026 as against Rs 243.46 crore during the previous quarter ended September 2025. Sales rose 24.26% to Rs 2820.47 crore in the quarter ended September 2026 as against Rs 2269.82 crore during the previous quarter ended September 2025.